Skip to main content

CITIGROUP INC

Position in LNTH — Lantheus Holdings, Inc.

CIK 831001 NEW YORK, NY

Position in LNTH

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$12,153,065
+$1,251,777 QoQ
Shares Held
160,225
-2.2% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Derivatives in LNTH

reported options exposure · as of Dec 31, 2020
CallValue
$0
CallShares
0
PutValue
$836
PutShares
62

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $466,960,504 across 57 Drug Manufacturers - Specialty & Generic names. LNTH ranks #8 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 LNTH
Lantheus Holdings, Inc.
This page
160,225 $12,153,065

All Filings in LNTH

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,153,065 160,225
2025-12-31 $10,901,288 163,806
2025-09-30 $1,024,670 19,978
2025-06-30 $4,679,606 57,166
2025-03-31 $8,409,019 86,158
2024-12-31 $8,701,593 97,268
2024-09-30 $7,246,242 66,025
2024-06-30 $2,751,938 34,275
2024-03-31 $1,888,360 30,340
2023-12-31 $1,451,482 23,411
2023-09-30 $1,852,544 26,663
2023-06-30 $4,211,608 50,186
2023-03-31 $4,422,655 53,569
2022-12-31 $939,395 18,434
2022-09-30 $2,894,078 41,150
2022-06-30 $2,560,377 38,776
2022-03-31 $3,361,462 60,775
2021-12-31 $1,509,329 52,244
2021-09-30 $1,128,738 43,954
2021-06-30 $1,070,054 38,714
2021-03-31 $188,846 8,837
2020-12-31 $836 62
2020-12-31 $245,693 18,213
2020-09-30 $569,174 44,923
2020-09-30 $785 62
2020-06-30 $886 62
2020-06-30 $1,406,733 98,373
2020-03-31 $856,144 67,096